AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Albaad Massuot Yitzhak Ltd.

Investor Presentation Nov 20, 2023

6630_rns_2023-11-20_953c54ee-1809-4bc5-9eef-1b42261eea62.pdf

Investor Presentation

Open in Viewer

Opens in native device viewer

Nov

2023

Financial Results Overview Q3.2023

1

FORWARD LOOKING STATEMENT

Legal disclaimer Important notice

This presentation (the "Presentation") is for informational purposes only and does not constitute or form any part of any offer for sale or subscription of, or solicitation of, any offer to buy or subscribe for any shares of Albaad Massuot Yitzhak LTD. (the "Company") or any of its affiliated entities.

This presentation contains partial information from the public reports of the Company under the Israeli Securities Law 5728-1968 (the "Securities Law"), which can be accessed on the Israeli Securities Authority's website, www.magna.isa.gov.il. A review of this presentation is not a substitute for a review of the detailed reports of the Company under the Securities Law and is not meant to replace or qualify them; rather, the presentation is prepared merely for the convenience of the reader, with the understanding that the detailed reports are being reviewed simultaneously.

Everything stated in this Presentation with respect to an analysis of the Company's business is merely a summary and any forwardlooking statements involve risks and uncertainties. These statements include descriptions regarding the intent, belief or current expectations of the Company. Such forward-looking statements are not guarantees of future results, performance or achievements and are based on current expectations, estimations, and assumptions, involve certain risks and uncertainties which are difficult to predict and are not guarantees of future performance. Therefore, actual future results, performances or achievements of the Company may differ materially from what is or may be expressed or implied in this presentation due to a variety of factors, many of which are beyond the Company's control, including, without limitation, certain risk factors contained in the Company's reports. The Company disclaims any obligation or commitment to update these forward-looking statements to reflect new information, future events or developments or changes in expectations, estimates, projections and assumptions or otherwise.

2023 OPERATING PLAN

EXECUTING OUR FINANCE STRENGTH PLAN

  • Achieving the initial banks covenants ahead of schedule
  • We reclassified 126 M NIS bank loans from short-term to long-term

FOCUSING ON PROFITABILITY IN OUR TARGET MARKETS

  • Growth in Wipes core activity in Europe & Tampons in the US market
  • * ** EBIT Increase of 241%, EBITDA Increase of 59% for Sep YTD

Q3.2023 COMPANY MAIN HIGHLIGHTS CONCLUDING THIRD QUARTER WITH

SALES INCREASE OF 21% TO 431 M NIS

** * • GROSS PROFIT MARGIN REACHED 20%EBIT INCREASE OF 31 M NIS TO 28 M NISEBITDA INCREASE OF 32 M NIS TO 50 M NIS

** • NET PROFIT INCREASE OF 34 M NIS TO 12 M NIS

*** • OPERATING CF 89 M NIS (FCF OF 53 M NIS)

NET DEBT DECREASE OF 42 M NIS TO 560 M NIS

* EBIT before others ** EBITDA & Net profit from continued operation *** FCF = Operating CF + Leasing liability repayment Interest + CAPEX

* SALES & EBITDA TRENDS 2021-2023

Quarterly basis (000 NIS)

Sales EBITDA

DIVERSE PRODUCT RANGE

Home Care

Wipes Disinfecting /All Purpose Cleaning / Windows / Floors / Furnitures / Automotive

Hygiene

Wipes Moist Toilet Paper Consumer Healthcare Adult Care

Baby Care

Wipes Based formulas: Aqua / Gel / Rich Lotion / Diaper Rash Cream / Bathing Wipes

Cosmetics

Wipes Makeup Remover / Hydrating / Exfoliating (abrasive) / Anti-aging

Fem. Care Tampons, Wipes Tampons: Tampon with a plastic applicator Tampon without applicator Tampon with a paper applicator

Intimate Wipes

ALBAAD's ADDED VALUE

Global deployment

  • ✓ Avoid Supply chain disruption
  • ✓ Back up plan in case of disruption in one of our facilities
  • ✓ Sufficient capacity in case market needs fast growing
  • ✓ Nonwoven Production Albaad produces majority of its own nonwoven consumption

Marketing

  • ✓ Identify and adjust the needs of each customer
  • ✓ Highly qualified team well experienced with A brands needs
  • ✓ Well informed on innovative raw materials (fabrics, laminate, Chemicals), products and customers trends worldwide

R&D

  • ✓ Well trained and highly educated R&D corporate's team – led by PhD.
  • ✓ Focuses on innovation
  • ✓ Expertise in all production chain – Fibers, Fabrics and End-Products

HIGHLIGHTS

Q3.2023 results VS. Last year(000 NIS)

+21% Sales Sales in original currency +4%

+31M Operating Profit Before Others

+172% EBITDA +32 M continued operation +78 M inc. discontinued operation

+79M

Net Profit From negative to positive

Q3 2023 Q3 2022 Var Var %
Sales 430,909 356,880 74,029 20.7%
EBIT 27,658 (10,977) 38,635
EBIT (Before Others) 27,662 (3,446) 31,108
EBITDA (Continued operation) 50,054 18,401 31,653 172.0%
EBITDA 51,186 (26,707) 77,893
Net Profit (Continued operation) 12,060 (22,360) 34,420
Net Profit 10,463 (69,013) 79,476
CF - Operating activities 89,075 32,900 56,175 170.7%

* SALES & EBIT BY DIVISION

Q3.2023 VS. Last year(000 NIS)

Sales *
EBIT
Q3 2023 Q3 2022 Var % Var % (Org.) Q3 2023 Q3 2022
Albaad Europe
% from sales
330,748 264,503 25.0% 5.3% 19,766
6.0%
4,233
1.6%
Albaad IL
% from sales
61,751 55,425 11.4% 3.9% 1,215
2.0%
865
1.6%
Albaad Fabric IL
% from sales
88,499 89,596 (1.2%) (16.9%) 3,818
4.3%
(3,565)
(4.0%)
Albaad Fem IL
% from sales
61,794 51,960 18.9% 6.7% 9,712
15.7%
(1,361)
(2.6%)
Intercompany (111,883) (104,604) (1,420) 1,341
HeadQuarter & Others (5,429) (4,959)
Total Company
% from sales
430,909 356,880 20.7% 4.1% 27,662
6.4%
(3,446)
(1.0%)
Other Income/Expenses (4) (7,531)
Total Company
% from sales
430,909 356,880 20.7% 4.1% 27,658
6.4%
(10,977)
(3.1%)

HIGHLIGHTS

Sep.2023 YTD results VS. Last year(000 NIS)

Sales
+19% Sales in original currency +7%

+241% Operating Profit Before Others

+59% EBITDA +50 M continued operation +119 M inc. discontinued operation

+104M

Net Profit From negative to positive

YTD Sep 23 YTD Sep 22 Var Var %
Sales 1,291,570 1,089,161 202,409 18.6%
EBIT 68,166 12,671 55,495 438.0%
EBIT (Before Others) 68,882 20,202 48,680 241.0%
EBITDA (Continued operation) 134,091 84,191 49,900 59.3%
EBITDA 129,133 10,384 118,749
Net Profit (Continued operation) 29,003 (5,716) 34,719
Net Profit 18,504 (85,405) 103,909
CF - Operating activities 179,472 2,833 176,639

* SALES & EBIT BY DIVISION

Sep.2023 YTD VS. Last year(000 NIS)

Sales *
EBIT
YTD Sep 23 YTD Sep 22 Var % Var % (Org.) YTD Sep 23 YTD Sep 22
Albaad Europe 969,408 804,233 20.5% 7.6% 39,918 31,063
% from sales 4.1% 3.9%
Albaad IL
% from sales
177,163 172,135 2.9% (1.6%) 804
0.5%
7,956
4.6%
Albaad Fabric IL
% from sales
271,109 272,499 (0.5%) (10.9%) 24,186
8.9%
1,135
0.4%
Albaad Fem IL
% from sales
193,877 149,521 29.7% 18.0% 30,003
15.5%
(7,416)
(5.0%)
Intercompany (319,987) (309,227) (8,037) 2,447
HeadQuarter & Others (17,992) (14,983)
Total Company
% from sales
1,291,570 1,089,161 18.6% 7.3% 68,882
5.3%
20,202
1.9%
Other Income/Expenses (716) (7,531)
Total Company
% from sales
1,291,570 1,089,161 18.6% 7.3% 68,166
5.3%
12,671
1.2%

Innovation & Future Growth Green product line in Dimona - the next generation

  • Green hybrid production line that enables production in both paper technology and green non-woven technology
  • The Hydrofine®Products from the new hybrid line will serve both flushable MTT wipes as well as traditional baby, cosmetic and cleaning wipes
  • All Hydrofine®Products are made from 100% natural, plant based components
  • Production is expected during H2 2024
  • Approximately 120 MNIS invested up to September 2023 from total budget of about 200 MNIS

BALANCE SHEET

AS OF 30.09.2023 VS. 31.12.2022 (000 NIS)

34M Cash on hand

60M Reduction of inventory +84 M excluding currency impact

392M Equity

24% Equity from total balance sheet

30.09.2023 % from total 31.12.2022 % from total
Cash and cash equivalents 34,279 2% 27,186 2%
Trade Receivables 234,940 14% 254,547 16%
Inventory 333,551 20% 393,313 25%
Other Current Assets 38,682 2% 37,580 2%
Total Current Assets 641,452 39% 712,626 45%
Non Current Assets 995,190 61% 883,964 55%
Total Assets 1,636,642 100% 1,596,590 100%
Credit banking & institutions *
409,515
25% 538,805 34%
Trade Payables 232,089 14% 252,518 16%
Total Current Liabilities 749,425 46% 910,734 57%
Total Long-Term Liabilities 494,721 30% 331,194 21%
Equity 392,496 24% 354,662 22%
Total liabilities 1,636,642 100% 1,596,590 100%

SUMMARY & FUTURE GROWTH

Meeting Banks Initial Covenants in Q3.2023

* Net Liabilities to EBITDA Ratio 2.83 / Equity Ratio 24.5%

Maintaining positive performance for EBITDA Growth & Operating Cash Flow

** Inventory reduction of 60 MNIS since Dec.2022 Cumulated Operating Cash Flow of 179 MNIS Cumulated Free Cash Flow of 95 MNIS including Dimona line 2 investments

Creating Future Growth Engines

  • Focusing on new profitable customers & Innovation products - expanding Europe sales teams
  • Establishing a quality private brand pave our way into price or innovation driven new markets
  • Innovation as state of mind in products, production & processes

THANK YOU

15

Talk to a Data Expert

Have a question? We'll get back to you promptly.